Start for free
Start for free
Biomatics Capital Partners logo

Biomatics Capital Partners

North America, Washington, United States, Seattle

Description

Biomatics Capital Partners is a Seattle-based healthcare and life sciences venture firm.

Investor Profile

Biomatics Capital Partners has made 26 investments, with 0 in the past 12 months and 15% as lead.

Stage Focus

  • Series A (38%)
  • Series B (35%)
  • Series C (19%)
  • Series Unknown (8%)

Country Focus

  • United States (96%)
  • China (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Genetics
  • Biopharma
  • Analytics
  • Artificial Intelligence (Ai)
  • Clinical Trials
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Biomatics Capital Partners frequently co-invest with?

New Leaf Venture Partners
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 3
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 5
Nan Fung Life Sciences
Nan Fung Life Sciences
North America, California, United States, San Francisco
Co-Investments: 3
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 8
Casdin Capital
Casdin Capital
North America, New York, United States, New York
Co-Investments: 4
Tribeca Venture Partners
Tribeca Venture Partners
North America, New York, United States, New York
Co-Investments: 3
F-Prime Capital
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
Decheng Capital
Decheng Capital
North America, California, United States, Menlo Park
Co-Investments: 3
Pritzker Group Venture Capital
Pritzker Group Venture Capital
North America, Illinois, United States, Chicago
Co-Investments: 3
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 13

Which angels does Biomatics Capital Partners often collaborate with?

George Godula
George Godula
Asia, Shanghai, China, Shanghai
Shared Deals: 1
BG
Bill Gates
North America, Washington, United States, Seattle
Shared Deals: 1
BB
Brook Byers
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Biomatics Capital Partners?

Encodia

San Diego, California, United States

Encodia is a biotech company that develops the next generation of protein analysis tools.

BiotechnologyChemical
Series CJan 27, 2021
Amount Raised: $75,000,000
Verve Therapeutics

Boston, Massachusetts, United States

Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.

BiotechnologyGeneticsLife Science
Series BJan 19, 2021
Amount Raised: $94,000,000
Thrive Earlier Detection

Cambridge, Massachusetts, United States

Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series BJul 29, 2020
Amount Raised: $257,000,000
Compass Therapeutics, Inc.

Boston, Massachusetts, United States

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

BiopharmaBiotechnologyTherapeutics
Series UnknownJul 1, 2020
Amount Raised: $60,482,210
Verve Therapeutics

Boston, Massachusetts, United States

Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.

BiotechnologyGeneticsLife Science
Series AJun 11, 2020
Amount Raised: $63,000,000
Omniome

San Diego, California, United States

Omniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.

BiopharmaBiotechnologyLife Science
Series CJan 9, 2020
Amount Raised: $60,000,000
EGenesis

Cambridge, Massachusetts, United States

EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.

BiopharmaBiotechnologyGeneticsLife ScienceMedical
Series BNov 7, 2019
Amount Raised: $100,000,000
AiCure

New York, New York, United States

AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.

AnalyticsArtificial Intelligence (AI)Clinical TrialsHealth CareMachine LearningMedicalSoftware
Series CNov 7, 2019
Amount Raised: $24,500,000
BlackThorn Therapeutics

San Francisco, California, United States

BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.

Artificial Intelligence (AI)BiotechnologyHealth CareTherapeutics
Series BJun 13, 2019
Amount Raised: $76,000,000
Thrive Earlier Detection

Cambridge, Massachusetts, United States

Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series AMay 30, 2019
Amount Raised: $110,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator